• Policy
• Gov’t will announce preferential pricing measures by June
• by Lee, Jeong-Hwan May 2, 2024 05:52am

• Policy
• Industry fumes over government's drug price reeval plan
• by Lee, Tak-Sun Apr 30, 2024 05:50am

• Policy
• Cancellation of Forxiga approval, HK inno.N gets indication
• by Lee, Tak-Sun Apr 30, 2024 05:50am

• Policy
• New PVA operation system will be implemented from May
• by Lee, Tak-Sun Apr 30, 2024 05:49am

• Policy
• Gov’t discloses draft for overseas drug price reevals
• by Lee, Tak-Sun Apr 29, 2024 05:50am

• Policy
• Jardiance under review for expanding reimb to kidney disease
• by Lee, Tak-Sun Apr 29, 2024 05:49am

• Policy
• Pharma companies with 'superior R&D·K-made drug ingredients
• by Lee, Jeong-Hwan Apr 26, 2024 05:48am

• Policy
• Prolia and Ryaltris adjust drug pricing
• by Lee, Tak-Sun Apr 23, 2024 05:40am

• Policy
• HK inno.N starts developing a Lixiana generic
• by Lee, Hye-Kyung Apr 23, 2024 05:36am

• Policy
• Atopic dermatitis drug Adtralza will be reimb in May
• by Lee, Jeong-Hwan Apr 22, 2024 05:45am